1 July 2026 in Physics of Fluids
Pupillary block in PACG impedes aqueous humor (AH) flow through the iris–lens channel (ILC), while existing models that simplify the ILC geometry fail to accurately capture this flow and its role in PACG pathophysiology. A computational model is developed to investigate AH flow in the anterior segment of the human eye, in which the ILC is represented as a porous medium with variable porosity to account for different ILC conditions. The ILC is modeled as an equivalent porous medium to represent effective flow resistance rather than a physiological porous structure. The governing flow and solid mechanics equations are solved to systematically examine the effects of pupillary block severity on AH flow, pressure distribution, iris deformation, and energy dissipation. The results demonstrate that ILC porosity plays a critical role in determining the severity of pupillary block and the extent of anterior chamber angle (ACA) closure. When the porosity decreases below 0.35, the posterior–anterior pressure difference increases sharply to 419.14 Pa, driving anterior iris displacement and subsequent contact with the trabecular meshwork, thereby inducing ACA closure and increasing flow resistance and energy dissipation. In contrast, for porosities above 0.35, iris deformation is reduced by up to 67%, the ACA remains open, and AH flows smoothly, indicating a significantly alleviated pupillary block condition. This study provides new insight into the role of the ILC in pupillary block and suggests a novel therapeutic strategy based on modulation of ILC porosity to improve AH dynamics in PACG.
1 October 2026 in Physics of Fluids
Low-concentration atropine is used for myopia control in children, but existing intraocular drug delivery models based on adult ocular geometry and physiological parameters may not accurately predict age-dependent drug transport in pediatric eyes. In this study, three-dimensional pediatric ocular drug transport models for children aged 4–7 and 8–12 years are established, incorporating age-dependent ocular geometries and physiological parameters to investigate the effects of age and dosing timing on intraocular heat transfer, biofluid flow, and atropine transport following topical administration. The results show that pediatric eyes exhibit lower temperature gradients in the anterior segment and lower peak aqueous humor and vitreous humor velocities than adult eyes, with the 4–7-year-old group exhibiting 9.95% and 13.20% lower peak atropine concentrations in the retina and choroid, respectively, but a 9.10% higher iris concentration than adults. Compared with nighttime dosing, daytime dosing increases the peak atropine concentrations in the retina and choroid by 18.98% and 18.02%, respectively. Under nighttime dosing, administration approximately 2 h before bedtime achieves target tissue concentrations comparable to those obtained with daytime dosing. These findings demonstrate the value of pediatric-specific ocular models incorporating age-dependent biological fluid dynamics, combined with optimized dosing timing, for predicting intraocular drug transport and improving atropine treatment strategies.